Paula Martinez Sanz

Research output

Research output per year 2021 2021 2023 2023

• 2 Article
• 1 Comment/Letter to the editor
• 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2023

  Humanized MISTRG as a preclinical in vivo model to study human neutrophil-mediated immune processes

  Martinez-Sanz, P., Laurent, A. R. G., Slot, E., Hoogenboezem, M., Bąbała, N., van Bruggen, R., Rongvaux, A., Flavell, R. A., Tytgat, G. A. M., Franke, K., Matlung, H. L., Kuijpers, T. W., Amsen, D. & Karrich, J. J., 2023, In: Frontiers in immunology. 14, 1105103.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)

• Innate killers at work: Strategies to exploit neutrophils for cancer treatment

  Martinez Sanz, P., 2023, 247 p.

  Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

  Open Access
• 2021

  Cd47-sirpα checkpoint inhibition enhances neutrophil-mediated killing of dinutuximab-opsonized neuroblastoma cells

  Martínez-Sanz, P., Hoogendijk, A. J., Verkuijlen, P. J. J. H., Schornagel, K., van Bruggen, R., van den Berg, T. K., Tytgat, G. A. M., Franke, K., Kuijpers, T. W. & Matlung, H. L., 1 Sept 2021, In: Cancers. 13, 17, 4261.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  13 Citations (Scopus)

• Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

  Martinez Sanz, P., van Rees, D. J., Matlung, H. L., Tytgat, G. A. M. & Franke, K., 1 Dec 2021, In: Journal for Immunotherapy of Cancer. 9, 12, e003983.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access